Clarivate

JUNE 21, 2022

Two novel events drove the 2020 data: the inclusion of Early Access content in the JCR for the first time, and the sudden appearance of COVID-19 as an entirely new, extremely urgent field of study. These factors made the 2020 data explored in last year’s release particularly unusual.

Prospecting 138

Prospecting Medical science Medicine Distribution 138

pharmaphorum

AUGUST 30, 2022

It was approved to reduce hospitalisation in heart failure patients in 2019, and then got the go-ahead for use in patients with heart failure with reduced ejection fraction (HFrEF) in 2020 on the strength of the DAPA-HF study.

Medical science 59

Medical science Patients Marketing Sales 59

PM360

AUGUST 29, 2022

As an example, a new NCQA HEDIS quality measure looking at the percentage of patients with type 2 diabetes (T2D) who had a kidney health evaluation in the last year was rolled out in 2020. Advance Medical Science.

Electronics 97

Electronics Patients Medical Healthcare 97

European Pharmaceutical Review

MAY 2, 2023

He received an MD from the Georg August University of Göttingen and completed a postdoctoral Master’s in Medical Sciences Clinical Pharmacology at the University of Glasgow. Dr Mieke Borgs has been Head of Clinical Operations Europe at BeiGene since May 2020.

Patients 105

Patients Medicine Marketing Medical 105

European Pharmaceutical Review

FEBRUARY 22, 2023

Results from the first open-label, single-centre study of RT-101,6 which was conducted in Australia, were reported at the start of 2020. 8 Future potential Celltrion sees potential for the platform to be applicable to other biologics, according to SungHyun Kim, Head of the company’s Medical Science Division.

Food and Drug Administration 105

Food and Drug Administration Manufacturing Safety Pharmaceutical 105

European Pharmaceutical Review

DECEMBER 28, 2023

About the interviewee Dr Andreas Harstrick joined Affimed as CMO in 2020, bringing with him more than 30 years of experience and expertise in cancer drug development, clinical trial research, and regulatory approvals. Andreas held several senior executive roles, including Senior Vice President of Medical Sciences at ImClone Systems, Inc.,

Food and Drug Administration 84

Food and Drug Administration Patients Safety Medical science 84

Veeva

FEBRUARY 6, 2022

According to Veeva Pulse data , COVID-19 has accelerated the shift to digital for life sciences, with significant growth in remote and digital engagement since early 2020, and a 10X increase of HCPs using three or more channels in their engagement with pharma 1.

Pharma 52

Pharma Medical Consulting Patients 52